Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin in cancer cachexia
NCT00329615Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- Jan 2000
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in cancer cachexia (2 arms), sponsored by University of Gothenburg. Primary endpoints: Health related quality of life, Food intake and 6 more. Started Jan 2000; status: completed.
02
Drugs
human insulin
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT00329615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329615.